The National COVID-19 Clinical Evidence Taskforce will receive $1.5 million from the Medical Research Future Fund (MRFF) to deliver ‘living guidelines’ on the clinical management of patients with suspected or confirmed COVID-19 infection across primary, acute and critical care settings. Media Release can be found here.
The Taskforce, which includes a large coalition of peak health professional bodies, has been convened by the Australian Living Evidence Consortium, led by Cochrane Australia based in the School of Public Health and Preventive Medicine, Monash University.
Congratulations to all Monash researchers involved in this work.
No comments:
Post a Comment